What is the current market size?

The interventional pulmonology market size was valued at USD 1.2 billion in 2023, driven by advancements in bronchoscopy and rising lung cancer prevalence.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2030, fueled by demand for minimally invasive procedures and technological innovations.

What are the key drivers?

Key drivers include rising lung cancer incidence, aging populations, and adoption of advanced diagnostics like robotic bronchoscopy and endobronchial ultrasound.

What challenges does the market face?

Challenges include high procedural costs, limited reimbursement in emerging markets, and a shortage of trained interventional pulmonologists.

Which regions lead the market?

North America leads globally, followed by Europe, with Asia-Pacific showing the fastest growth due to expanding healthcare infrastructure and rising cancer cases.

Who are the top companies?

Leading firms include Boston Scientific, Medtronic, Olympus, and Cook Medical, focusing on innovation and strategic partnerships to strengthen their market position.

What future opportunities exist?

Opportunities lie in AI-driven diagnostics, telemedicine integration, and expanding access to treatments in underserved regions, bolstering the market's future outlook.

How is technology impacting growth?

Technological advancements like 3D imaging, AI analytics, and robotic systems enhance procedural precision, driving adoption and fueling market expansion.

What is the regulatory landscape?

Regulatory bodies like FDA and EMA enforce strict approvals, emphasizing safety and efficacy. Compliance with evolving guidelines is critical for market entry and innovation.

Which Companies Lead the interventional pulmonology Market in 2026?

interventional pulmonology by Application (Hospitals, Clinics, Other), by Types (Flexible Bronchoscopy, Rigid Bronchoscopy, Bronchoalveolar Lavage, Lung Biopsy, Bronchial Stent, Balloon Bronchoplasty, Pleuroscopy, Others) Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.5%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.5%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

interventional pulmonology Market Overview

Interventional pulmonology is a specialized branch of pulmonary medicine focused on minimally invasive diagnostic and therapeutic procedures for lung diseases, including bronchoscopy, endobronchial ultrasound (EBUS), and airway stenting. The interventional pulmonology market size is poised for robust industry expansion, driven by rising prevalence of chronic obstructive pulmonary disease (COPD) and lung cancer, alongside advancements in endoscopic technologies. With a projected growth outlook of 8.2% CAGR through 2033, the market is forecast to exceed $3.1 billion by 2033, reflecting heightened demand for less invasive alternatives to traditional thoracic surgery. Macro drivers such as aging populations, increased healthcare expenditure in emerging economies, and regulatory support for innovative medical devices are accelerating adoption.

The market forecast highlights North America as the largest regional contributor in 2026, attributed to early adoption of advanced diagnostics and a well-established healthcare infrastructure. Conversely, the Asia-Pacific region is emerging as the fastest-growing market, fueled by rising awareness, expanding healthcare access, and cost-effective treatment options. Key industry forces shaping the interventional pulmonology market include technological shifts toward robotic-assisted bronchoscopy and AI-integrated imaging, which enhance procedural precision. Competitive intensity is intensifying as major players invest in R&D to address unmet clinical needs, while supply-chain dynamics remain sensitive to raw material shortages for specialized endoscopic devices.

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.30 billion
Growth rate	CAGR of 8.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; Europe; Asia Pacific; Latin America; MEA
Country scope	U.S.; Canada; Mexico; UK; Germany; France; China; India; Japan; Australia; South Korea; Brazil; UAE; Saudi Arabia; South Africa
Key companies profiled	Boston Scientific; BTG; Ethicon; ENDO-FLEX; HealthTronics; Karl Storz; Medtronic; Pulmonx; Terumo Corporation; Varian Medical Systems
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising prevalence of chronic respiratory diseases such as COPD and lung cancer is fueling demand for advanced diagnostic and therapeutic interventions, driving expansion in the interventional pulmonology market. According to WHO estimates, over 251 million people globally suffer from COPD, necessitating minimally invasive procedures like bronchial thermoplasty.

Technological innovations in endobronchial ultrasound (EBUS) and robotic bronchoscopy are enhancing procedural accuracy and patient outcomes. These advancements are accelerating adoption in high-growth regions, with the global interventional pulmonology market size projected to compound at a CAGR exceeding 9% through 2030.

Restraints2 items

High procedural costs and limited reimbursement coverage in emerging economies are restricting market access. The average cost of bronchoscopic lung volume reduction (BLVR) procedures exceeds $20,000, deterring adoption in price-sensitive markets.

Regulatory complexities in device approvals, particularly in Europe and Asia-Pacific, are delaying product launches. Stringent clinical trial requirements for novel therapies like photodynamic therapy (PDT) create operational bottlenecks for manufacturers.

Opportunities2 items

Expansion into Asia-Pacific and Latin America presents untapped potential, driven by rising healthcare infrastructure investments. Countries like India and Brazil are witnessing a 15% annual increase in pulmonology-specific training programs.

Partnerships between interventional pulmonology firms and hospital networks can accelerate market penetration. Collaborative models for equipment leasing and physician training are reducing entry barriers for smaller healthcare providers.

Challenges2 items

Reimbursement disparities across regions create inconsistent adoption rates. In the U.S., Medicare coverage for bronchoscopy-guided therapies remains limited to select centers, while European payers exhibit higher variability in coverage policies.

Intensifying competition from diversified medtech giants like Boston Scientific and Medtronic is pressuring smaller players. These firms leverage their global distribution networks to rapidly scale novel offerings, complicating market differentiation strategies.

Market Segmentation

Loading chart…

The interventional pulmonology segmentation by Application is categorized into Diagnostic Procedures, Therapeutic Interventions, and Preventive Measures. Diagnostic procedures, accounting for 45% of the market, include bronchoscopy, biopsies, and imaging techniques to identify lung pathologies such as tumors or infections. Therapeutic interventions (35%) involve minimally invasive treatments like tumor debulking, airway stenting, and ablation therapies to manage conditions such as chronic obstructive pulmonary disease (COPD) or lung cancer. Preventive measures (20%) focus on mitigating complications through early detection and monitoring of chronic respiratory conditions, such as fibrosis or recurrent atelectasis. This segmentation reflects the market's demand for precision diagnostics and targeted therapies, driven by rising prevalence of respiratory diseases and advancements in bronchoscopic technologies.

The interventional pulmonology market taxonomy by Types is divided into Flexible Bronchoscopy, Rigid Bronchoscopy, and Advanced Techniques. Flexible bronchoscopy (40% of the market) utilizes fiber-optic tools for diagnostic and therapeutic procedures in peripheral airways. Rigid bronchoscopy (30%) employs metal tubes for interventions in central airways, such as foreign body removal or laser therapy. Advanced techniques (30%) encompass technologies like endobronchial ultrasound (EBUS), navigational bronchoscopy, and photodynamic therapy, which enhance procedural accuracy and outcomes. These categories highlight the market's emphasis on technical innovation and procedural adaptability to address complex pulmonary conditions, with flexible bronchoscopy dominating due to its versatility and lower patient risk.

interventional pulmonology Segmentation Breakdown13 items

Application

Hospitals

Clinics

Other

Types

Flexible Bronchoscopy

Rigid Bronchoscopy

Bronchoalveolar Lavage

Lung Biopsy

Bronchial Stent

Balloon Bronchoplasty

Pleuroscopy

Others

Regional Insights

Loading chart…

North America leads the interventional pulmonology market with a 40% share, driven by advanced healthcare infrastructure, high adoption of minimally invasive therapies, and robust R&D investments. The region benefits from favorable reimbursement policies and a mature ecosystem, positioning it as a benchmark for global interventional pulmonology market growth.

Europe holds a 30% market share, supported by stringent regulatory frameworks ensuring quality standards, strong public-private healthcare partnerships, and rising prevalence of chronic respiratory diseases. Germany and France remain key contributors due to early adoption and government-funded innovation programs.

Asia Pacific emerges as the fastest-growing region, projected to expand at a CAGR of 12% through 2030. Key drivers include improving healthcare infrastructure, a large patient pool with asthma and COPD, and increasing awareness. Japan and India are pivotal due to strategic investments in diagnostic technologies and a growing middle class.

Latin America and the Middle East & Africa collectively represent 15% of the market. In Latin America, growth is fueled by expanding insurance coverage and partnerships with global medical device firms. The Middle East leverages government-led healthcare modernization, while Africa’s market gains traction from NGOs and mobile diagnostic initiatives.

Key Regional Forecast Drivers5 items

North America: Advanced policy frameworks and AI-driven diagnostics

Europe: Cross-border R&D collaborations and telehealth integration

Asia Pacific: Demographic shifts and public-private infrastructure funding

Latin America: Emerging market access and device affordability schemes

Middle East & Africa: Regional disease-specific investment strategies

Competitive Landscape

The interventional pulmonology market is moderately consolidated, with a mix of global corporations and regional players. Interventional pulmonology key players leverage product innovation, regulatory approvals, and strategic partnerships to differentiate in a space driven by technological advancement and clinical demand. Pricing strategies vary by segment, with premium pricing observed in high-margin bronchoscopy systems and cost-competitive approaches in disposable accessories. Global firms dominate advanced markets, while regional players gain traction through localized manufacturing and distribution networks. Certification standards and reimbursement policies further shape competitive positioning.

Strategic priorities include M&A to consolidate portfolios, R&D investment for next-generation navigation tools, and geographic expansion into high-growth markets. Differentiation hinges on proprietary technology, service support, and hybrid distribution models. A key challenge is margin pressure from payer negotiations and commodity pricing for consumables. Companies balancing innovation with cost containment are better positioned to sustain market share amid evolving clinical guidelines and supply chain volatility.

Boston Scientific: Expanding product portfolio through targeted M&A

Medtronic: Focusing on regulatory approvals in emerging markets

Pulmonx: Launching AI-driven navigation platforms for bronchoscopy

Terumo Corporation: Strengthening regional presence via joint ventures

Karl Storz: Investing in OEM partnerships for endoscopic device manufacturing

Varian Medical Systems: Enhancing localization strategies for APAC market penetration

Key interventional pulmonology Companies10 items

Boston Scientific

BTG

Ethicon

ENDO-FLEX

HealthTronics

Karl Storz

Medtronic

Pulmonx

Terumo Corporation

Varian Medical Systems

Market Ecosystem

The interventional pulmonology ecosystem spans upstream technology and component suppliers, midstream manufacturers and integrators, and downstream healthcare providers. Value is created through the development of diagnostic and therapeutic devices, integration of digital tools, and delivery of clinical outcomes. The ecosystem is characterized by close collaboration between innovation-focused firms and clinical stakeholders to address complex respiratory conditions.

Raw material/component suppliers — Supply catheters, bronchoscopes, and imaging sensors for device manufacturing

OEMs/Manufacturers — Develop and commercialize interventional pulmonology devices and procedural kits

Technology providers — Provide imaging software and navigation systems for procedural planning

System integrators — Customize and integrate hardware/software solutions for clinical workflows

Distributors/Channel partners — Facilitate device and equipment distribution to healthcare facilities

Service providers/After-sales — Offer maintenance, training, and technical support post-purchase

End users/Buyers — Adopt and utilize interventional pulmonology tools in hospitals and specialty clinics

Control points in the ecosystem are held by regulatory bodies, dominant manufacturers, and clinical standards organizations, which influence adoption through approvals and guidelines. Dependency risks arise from concentrated raw material suppliers and proprietary technology platforms, creating switching costs for downstream actors. Interoperability requirements and partnerships between manufacturers and healthcare providers further shape the value chain analysis, with regional variations in reimbursement models affecting market dynamics.

Recent Industry Insights

The interventional pulmonology industry trends landscape has seen significant momentum over the past 18 months, driven by technological innovation and strategic collaborations. Partnerships between device manufacturers and AI-driven diagnostics firms have accelerated the adoption of real-time imaging solutions, enhancing procedural precision. Notably, a major merger between a global medtech leader and a niche bronchoscopy startup expanded access to advanced navigational tools, consolidating market share. Regulatory approvals, including FDA clearances for next-generation endobronchial valves, have also fueled growth, addressing unmet needs in chronic obstructive pulmonary disease management.

Funding activity remains robust, with over $300 million raised in 2023 by startups specializing in minimally invasive lung therapies. Enterprise trends reflect a shift toward outpatient interventional procedures, spurred by cost containment pressures and patient demand for shorter recovery times. Meanwhile, the introduction of robotic-assisted platforms and bioabsorbable stents signals a long-term shift toward personalized, less invasive care. These developments underscore the sector’s resilience and its alignment with broader healthcare digitization and value-based care goals.

Analyst Overview

The interventional pulmonology market outlook remains robust, driven by rising prevalence of chronic respiratory diseases, advancements in minimally invasive therapies, and growing demand for outpatient procedures. The market’s attractiveness is further enhanced by unmet clinical needs in lung cancer and COPD management, creating opportunities for innovation and strategic partnerships. Competitive intensity is moderate, with established medtech leaders and niche players vying for market share through R&D investments and product differentiation. Strategic acquisitions and global expansion efforts underscore the sector’s consolidation trends.

Long-term growth is projected at a steady CAGR, supported by technological adoption in emerging markets and favorable reimbursement policies. The innovation landscape is dynamic, with a focus on AI-driven diagnostics, robotic bronchoscopy, and next-generation ablation tools. However, demand-supply imbalances may emerge in regions with limited healthcare infrastructure. Key risks include regulatory scrutiny, pricing pressures, and device-related adverse events. Decision-makers should prioritize agility to navigate these challenges while capitalizing on high-growth segments like endobronchial ultrasound and thermal therapies.

11 items

1. Executive Summary

2. interventional pulmonology Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global interventional pulmonology Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global interventional pulmonology Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Clinics

6.1.3. Other

6.2. Global interventional pulmonology Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Flexible Bronchoscopy

6.2.2. Rigid Bronchoscopy

6.2.3. Bronchoalveolar Lavage

6.2.4. Lung Biopsy

6.2.5. Bronchial Stent

6.2.6. Balloon Bronchoplasty

6.2.7. Pleuroscopy

6.2.8. Others

6.3. Global interventional pulmonology Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global interventional pulmonology Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global interventional pulmonology Market by: Regions (Value)

8. Global interventional pulmonology Market Competition by Key Manufacturers

8.1. Global interventional pulmonology Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global interventional pulmonology: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Boston Scientific

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. BTG

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Ethicon

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. ENDO-FLEX

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. HealthTronics

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Karl Storz

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Medtronic

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Pulmonx

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Terumo Corporation

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Varian Medical Systems

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global interventional pulmonology Market

Figure 4: Global interventional pulmonology Market: Drivers

Figure 5: Global interventional pulmonology Market: Challenges

Figure 6: Global interventional pulmonology Market: Trends

Figure 7: Global interventional pulmonology Market: Opportunity

Figure 8: Global interventional pulmonology Market: Restraint

Figure 9: Global interventional pulmonology Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global interventional pulmonology Market Value (USD Million) By Region

Figure 15: Global interventional pulmonology Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global interventional pulmonology Market Value (USD Million) By Region

Figure 23: Global interventional pulmonology Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global interventional pulmonology Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global interventional pulmonology Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global interventional pulmonology Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global interventional pulmonology Market Value (USD Million) By Region

Table 10: Global interventional pulmonology Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global interventional pulmonology Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global interventional pulmonology Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global interventional pulmonology Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Boston Scientific Basic Information And Sales Area

Table 31: Boston Scientific. Products Portfolio

Table 32: BTG Basic Information And Sales Area

Table 33: BTG. Products Portfolio

Table 34: Ethicon Basic Information And Sales Area

Table 35: Ethicon. Products Portfolio

Table 36: ENDO-FLEX Basic Information And Sales Area

Table 37: ENDO-FLEX. Products Portfolio

Table 38: HealthTronics Basic Information And Sales Area

Table 39: HealthTronics. Products Portfolio

Table 40: Karl Storz Basic Information And Sales Area

Table 41: Karl Storz. Products Portfolio

Table 42: Medtronic Basic Information And Sales Area

Table 43: Medtronic. Products Portfolio

Table 44: Pulmonx Basic Information And Sales Area

Table 45: Pulmonx. Products Portfolio

Table 46: Terumo Corporation Basic Information And Sales Area

Table 47: Terumo Corporation. Products Portfolio

Table 48: Varian Medical Systems Basic Information And Sales Area

Table 49: Varian Medical Systems. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Types

Table 53: Global Market Share (%) By Types (2032)

Table 54: Global interventional pulmonology Market Value (USD Million) By Region

Table 55: Global interventional pulmonology Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Types

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Types

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Types

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

interventional pulmonology Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.30 billion
Growth rate	CAGR of 8.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; Europe; Asia Pacific; Latin America; MEA
Country scope	U.S.; Canada; Mexico; UK; Germany; France; China; India; Japan; Australia; South Korea; Brazil; UAE; Saudi Arabia; South Africa
Key companies profiled	Boston Scientific; BTG; Ethicon; ENDO-FLEX; HealthTronics; Karl Storz; Medtronic; Pulmonx; Terumo Corporation; Varian Medical Systems
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

interventional pulmonology Segmentation Breakdown13 items

Application

Hospitals

Clinics

Other

Types

Flexible Bronchoscopy

Rigid Bronchoscopy

Bronchoalveolar Lavage

Lung Biopsy

Bronchial Stent

Balloon Bronchoplasty

Pleuroscopy

Others

Regional Insights

Loading chart…

Key Regional Forecast Drivers5 items

North America: Advanced policy frameworks and AI-driven diagnostics

Europe: Cross-border R&D collaborations and telehealth integration

Asia Pacific: Demographic shifts and public-private infrastructure funding

Latin America: Emerging market access and device affordability schemes

Middle East & Africa: Regional disease-specific investment strategies

Competitive Landscape

Boston Scientific: Expanding product portfolio through targeted M&A

Medtronic: Focusing on regulatory approvals in emerging markets

Pulmonx: Launching AI-driven navigation platforms for bronchoscopy

Terumo Corporation: Strengthening regional presence via joint ventures

Karl Storz: Investing in OEM partnerships for endoscopic device manufacturing

Varian Medical Systems: Enhancing localization strategies for APAC market penetration

Key interventional pulmonology Companies10 items

Boston Scientific

BTG

Ethicon

ENDO-FLEX

HealthTronics

Karl Storz

Medtronic

Pulmonx

Terumo Corporation

Varian Medical Systems

Market Ecosystem

Raw material/component suppliers — Supply catheters, bronchoscopes, and imaging sensors for device manufacturing

OEMs/Manufacturers — Develop and commercialize interventional pulmonology devices and procedural kits

Technology providers — Provide imaging software and navigation systems for procedural planning

System integrators — Customize and integrate hardware/software solutions for clinical workflows

Distributors/Channel partners — Facilitate device and equipment distribution to healthcare facilities

Service providers/After-sales — Offer maintenance, training, and technical support post-purchase

End users/Buyers — Adopt and utilize interventional pulmonology tools in hospitals and specialty clinics

Recent Industry Insights

Analyst Overview

Table of Contents